Psych meds developer Neumora Therapeutics files for $100M IPO


Large yellow signboard on metal frame with the word IPO


Neumora Therapeutics (NMRA), which is developing drugs to treat psychiatric disorders such as schizophrenia and depression, has filed to raise around $100M through an initial public offering.

Neumora didn’t specify terms in its filing, but indicated in a filing fee

Source link

Leave A Reply

Your email address will not be published.